Carsten Kobe

15PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersHaematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Animal physiological ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

|Jun 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

|Apr 02, 2026
Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Anne Sophie Robertz, Ina Bühnen, Julia Meissner

|Jul 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.

Justin Ferdinandus, Helen Kaul, Alexander Fosså

|Oct 16, 2023
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.

Michael Fuchs, Anne Sophie Jacob, Helen Kaul

|Dec 12, 2022
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.

Paul J Bröckelmann, Ina Bühnen, Julia Meissner

Pageof 3

Frequent Collaborators

9 joint publications

Paul J Bröckelmann

7 joint publications

Bastian von Tresckow

5 joint publications

Dennis A Eichenauer

5 joint publications

Justin Ferdinandus